The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Astellas Oncology; AstraZeneca; Bayer; Bristol-Myers Squibb; Ipsen; Janssen; MSD; Novartis; Pfizer; Roche; Sanofi
Consulting or Advisory Role - Bristol-Myers Squibb; Ipsen; Novartis; Pfizer; Roche
Travel, Accommodations, Expenses - Astellas Oncology; Bayer; Bristol-Myers Squibb; Ipsen; Janssen; MSD; Novartis; Pfizer; Roche; Sanofi
The EVERPRO study: Final results of a non-interventional study (NIS) evaluating the quality of life (QoL) in second-line treatment of metastatic renal cell carcinoma (mRCC) with everolimus.
 
Peter-Juergen Goebell
No Relationships to Disclose
 
Edwin Herrmann
Honoraria - Novartis
Consulting or Advisory Role - Novartis
 
Ulrich Kube
No Relationships to Disclose
 
Christian Doehn
Stock and Other Ownership Interests - AstraZeneca; Bayer; Bristol-Myers Squibb
Honoraria - Amgen; Bayer; Bristol-Myers Squibb; GlaxoSmithKline; Novartis; Pfizer; Roche
Consulting or Advisory Role - Amgen; Bayer; Bristol-Myers Squibb; Eisai; GlaxoSmithKline; Ipsen; Novartis; Pfizer; Roche
 
Norbert Walter Marschner
Honoraria - Amgen; Celgene; Lilly; Novartis; Roche; Saadoz
Consulting or Advisory Role - Novartis
Speakers' Bureau - Novartis
Research Funding - Amgen (Inst); Celgene (Inst); Novartis (Inst); Roche (Inst); Sandoz (Inst)
Travel, Accommodations, Expenses - Amgen; Celgene; Lilly; Novartis; Roche
 
Anja Dietel
No Relationships to Disclose
 
Klaus Blumenstengel
No Relationships to Disclose
 
Marc-Oliver Grimm
Honoraria - Apogepha; Astellas Oncology; AstraZeneca; Bayer; Bristol-Myers Squibb; Hexal; Janssen; Jenapharm; Novartis; Pfizer; Pierre Fabre; Sanofi
Consulting or Advisory Role - Amgen; Astellas Oncology; AstraZeneca; Bayer; Bristol-Myers Squibb; Hexal; Intuitive Surgical; Janssen-Cilag; MSD; Novartis; Pfizer; Sanofi/Aventis
Research Funding - Bristol-Myers Squibb (Inst); Novartis (Inst)
 
Michael Thomas Scheffler
No Relationships to Disclose
 
Anja Rogler
Employment - Novartis
 
Lothar Bergmann
Consulting or Advisory Role - Bristol-Myers Squibb; Eisai; Ipsen; Novartis; Pfizer; Roche
Research Funding - Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - Ipsen; Pfizer; Roche (I)